SLC4A1AP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.398800E-01
Normal-vs-Stage2
4.086600E-01
Normal-vs-Stage3
7.216000E-02
Normal-vs-Stage4
5.652200E-01
Stage1-vs-Stage2
7.981400E-01
Stage1-vs-Stage3
1.081630E-01
Stage1-vs-Stage4
1.881240E-01
Stage2-vs-Stage3
1.264980E-01
Stage2-vs-Stage4
8.443500E-02
Stage3-vs-Stage4
4.626000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.109800E-01
Normal-vs-AfricanAmerican
5.550200E-01
Normal-vs-Asian
5.608500E-02
Caucasian-vs-AfricanAmerican
9.983800E-01
Caucasian-vs-Asian
3.968100E-02
AfricanAmerican-vs-Asian
1.606450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.629400E-01
Normal-vs-Female
4.712000E-01
Male-vs-Female
8.284200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.232200E-01
Normal-vs-Age(41-60Yrs)
7.646400E-01
Normal-vs-Age(61-80Yrs)
3.616600E-01
Normal-vs-Age(81-100Yrs)
3.215200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.985200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.127400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.306400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.286100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.232800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.913600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.073200E-01
Normal-vs-Daily Drinker
3.401200E-01
Normal-vs-Weekly Drinker
6.244000E-01
Normal-vs-Occasional Drinker
9.863400E-01
Normal-vs-Social Drinker
4.974000E-01
Non Drinker-vs-Daily Drinker
8.063000E-01
Non Drinker-vs-Weekly Drinker
5.540400E-01
Non Drinker-vs-Occasional Drinker
1.561680E-02
Non Drinker-vs-Social Drinker
2.918800E-01
Daily Drinker-vs-Weekly Drinker
6.602600E-01
Daily Drinker-vs-Occasional Drinker
6.055900E-02
Daily Drinker-vs-Social Drinker
4.846800E-01
Weekly Drinker-vs-Occasional Drinker
3.078800E-01
Weekly Drinker-vs-Social Drinker
9.077400E-01
Occasional Drinker-vs-Social Drinker
2.427000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.613400E-01
Normal-vs-Grade 2
6.688400E-01
Normal-vs-Grade 3
5.806600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.183400E-01
Grade 1-vs-Grade 3
3.822300E-02
Grade 1-vs-Grade 4
3.613400E-01
Grade 2-vs-Grade 3
2.713900E-02
Grade 2-vs-Grade 4
6.688400E-01
Grade 3-vs-Grade 4
5.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.908200E-01
Normal-vs-NonDiabetic
3.462800E-01
Diabetic-vs-NonDiabetic
9.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.614360E-01
Normal-vs-NoPancreatitis
4.372000E-01
Pancreatitis-vs-NoPancreatitis
5.865400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.716200E-01
Normal-vs-N1
4.473400E-01
N0-vs-N1
5.744000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.294000E-01
Normal-vs-TP53-NonMutant
5.145000E-01
TP53-Mutant-vs-TP53-NonMutant
2.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
